# ELUXADOLINE
> **ANDA213613** · Abbreviated New Drug Application (Generic) · Sponsor: ASCEND LABORATORIES, LTD · Approved 2021-12-17
## Drug
- **FDA Application Number:** ANDA213613
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ELUXADOLINE
- **Generic name:** Eluxadoline
- **Active ingredients:** ELUXADOLINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ASCEND LABORATORIES, LTD
- **First approval:** 2021-12-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213613)
---
*MORVS · CC0 1.0*